Researchers urge a moratorium on prescribing chloroquine or hydroxychloroquine, with or without azithromycin, to treat or prevent COVID-19, and caution that the reassuring safety profile of hydroxychloroquine may be more apparent than real. Safety data derive from decades of prescriptions by clinicians, primarily for their patients with lupus and rheumatoid arthritis, both of which are of greater prevalence in younger and middle age women, who are at very low risk of fatal heart outcomes due to hydroxychloroquine.
- Amount of COVID viral RNA detected at hospital admission predicts how patients will fare
- Study finds 5 distinct dog types from 11,000 years ago
- Tube-dwelling anemone toxins have pharmacological potential, mapping study shows
- Autoantibody order, timing predict genetically at-risk children most likely to get T1D
- Landscape to atomic scales: Researchers apply new approach to pyrite oxidation